Changes in Beneficial Ownership · 4
10x Genomics, Inc.
TXGNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-09-09
- Issuer
- 10x Genomics, Inc.
- Issuer CIK
- 0001770787
- Trading symbol
- TXG
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Taich Adam
- Reporting owner CIK
- 0001971187
- Relationship
- Officer
- Officer title
- Chief Financial Officer
- Address
- 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | 2026-09-09 | S · Form 4[F1] | 1,206 | D | 63.6774[F2] | 361,526 | D |
| Class A Common Stock | 2026-09-09 | S · Form 4[F1] | 31,428 | D | 64.3097[F3] | 330,098 | D |
| Class A Common Stock | 2026-09-09 | S · Form 4[F1] | 13,754 | D | 65.2574[F4] | 316,344 | D |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Direct
Footnotes
- F1
- The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 10, 2026.↩ 1↩ 2↩ 3
- F2
- This transaction was executed in multiple trades at prices ranging from $63.67 to $63.83, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.↩ 1
- F3
- This transaction was executed in multiple trades at prices ranging from $64.01 to $64.87, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.↩ 1
- F4
- This transaction was executed in multiple trades at prices ranging from $64.88 to $65.875, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.↩ 1
Signature 1
- Signed
- /s/ Randy Wu, as Attorney-in-Fact for Adam Taich
- Date
- 2026-09-11
Company context
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.